Over the past decades, the trajectory of podocyte biology and glomerular medicine has evolved into a globally connected, interdisciplinary field at the interface of cell biology, systems medicine, and clinical nephrology. The insight that the podocyte is not merely a structural component, but a key orchestrator of glomerular integrity and function, has fundamentally transformed our understanding of glomerular health and disease. From early discoveries in cell architecture and signaling to the identification of podocyte-specific genes and the application of high-resolution imaging and omics technologies, each milestone has opened new avenues of investigation. Today, podocyte biology informs diagnostic frameworks, contributes to biomarker development, guides clinical trial design, and supports current and future targeted therapies. Building on the community’s combined achievements, the International Podocyte Meeting has evolved into the main meeting of the International Society of Glomerular Disease (ISGD)—bringing together podocyte biology, glomerular biology, glomerular diseases, and glomerular medicine. This progression—spanning fundamental research, translational approaches, and patient-centered therapy—is also reflected in this abstract compilation. Advancing research relies on global exchange between experts from diverse disciplines, which the International Podocyte Conference has enabled since its 1999 inauguration. We are particularly grateful to all participants joining us this year and acknowledge the many organizations and sponsors whose support has helped make this conference possible. We are especially thankful for the continued partnership with NephCure, which has always played a key role in aligning podocyte research with patient-centered goals. We thank ISGD for supporting this meeting and helping to establish podocyte biology within a broader institutional framework. Our appreciation also goes to our local organizing team and host institutions for their effective and collegial cooperation. With this compilation, we hope to inspire rich discussion, promote collaboration, and attract the next generation of researchers to the field of podocyte biology and glomerular medicine.

Journal Section:
Abstracts
This content is only available via PDF.
The Author(s). Published by S. Karger AG, Basel
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License .
Attribution-NonCommercial